Havrix®
Showing 1 - 25 of >10,000
Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)
Recruiting
- Rheumatic Diseases
- Hepatitis A vaccine
- Diphtheria, pertussis, and tetanus booster vaccine
-
Portland, OregonOregon Health & Science University
Sep 14, 2022
Malaria Trial in Bamako (Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine))
Active, not recruiting
- Malaria
- Pfs230D1M-EPA/AS01
- +4 more
-
Bamako, MaliMrtc/Usttb
Jul 29, 2022
Hepatitis A, Hep A Trial in Suwon, Chiang Mai (Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5
Not yet recruiting
- Hepatitis A
- Hep A
- Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL
- HAVRIX 720 Junior 0.5 mL
-
Suwon, Korea, Republic of
- +1 more
Nov 4, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus Trial in Singapore (CYD Dengue vaccine, NaCl + influenza virus or hepatitis
Completed
- Dengue Fever
- +3 more
- CYD Dengue vaccine
- NaCl + influenza virus or hepatitis A vaccine
-
Singapore, Singapore
- +4 more
Mar 10, 2022
COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)
Terminated
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +2 more
-
Kyiv, Ukraine
- +3 more
May 19, 2022
Encephalitis Trial in Muntinlupa, Manila (IC51 Japanese Encephalitis, Havrix®720, Prevnar)
Completed
- Encephalitis
- IC51 Japanese Encephalitis
- +2 more
-
Muntinlupa, Filinvest Corporate City, Philippines
- +1 more
Jul 5, 2021
Qualitative, Qualitative, and Functional Studies Over First Year
Completed
- Astrocytoma
- +2 more
- Hepatitis A Vaccine
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 28, 2021
Pneumococcal Vaccine on Nasopharyngeal Carriage
Completed
- Pneumococcal Infections
- PCV GSK1024850A
- hepatitis B vaccine or hepatitis A vaccine
-
Tampere, FinlandNational Institute for Health and Welfare
Feb 3, 2021
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Helsinki (Pneumococcal conjugate vaccine GSK1024850A, GSK
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine GSK1024850A
- +2 more
-
Helsinki, FinlandGSK Investigational Site
Nov 20, 2020
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Poland (GSK1024805A, Prevenar, Infanrix hexa)
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- GSK1024805A
- +4 more
-
Bydgoszcz, Poland
- +5 more
Jan 11, 2021
Hepatitis A Vaccine Trial in Panama (Blood sample collection)
Completed
- Hepatitis A Vaccine
- Blood sample collection
-
Chiriquí, Panama
- +3 more
Nov 5, 2019
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Finland (Pneumococcal conjugate vaccine Synflorix (GSK1024850A),
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine Synflorix (GSK1024850A)
- +2 more
-
Espoo, Finland
- +14 more
Nov 20, 2020
Healthy Volunteers (Meningococcal Infection) Trial in Puerto Rico, United States (MenACYW conjugate vaccine, MenACYW-135
Active, not recruiting
- Healthy Volunteers (Meningococcal Infection)
- MenACYW conjugate vaccine
- +8 more
-
Birmingham, Alabama
- +69 more
Jan 3, 2023
Healthy Participants Trial in Memphis (Vitamin A supplementation, No vitamin A supplementation)
Recruiting
- Healthy Participants
- Vitamin A supplementation
- No vitamin A supplementation
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 29, 2022
Hepatitis A Trial in Changzhou (Healive® Lot 1, Healive® Lot 2, Healive® Lot 3)
Completed
- Hepatitis A
- Healive® Lot 1
- +3 more
-
Changzhou, Jiangsu, ChinaChangzhou City Center for Disease Control and Prevention
Aug 29, 2019
Hepatitis A Vaccine Trial in Korea, Republic of (inactivated hepatitis A vaccine, Havrix Inj)
Completed
- Hepatitis A Vaccine
- inactivated hepatitis A vaccine
- Havrix Inj
-
Seoul, Banpo-dong, Seocho-gu, Korea, Republic of
- +11 more
Mar 19, 2020
Hepatitis B, Hepatitis A Trial in Belgium, Czechia, Germany (TWINRIX™, Engerix™-B, HAVRIX™)
Completed
- Hepatitis B
- Hepatitis A
- TWINRIX™
- +4 more
-
Wilrijk, Belgium
- +8 more
Oct 29, 2019
Transplant-Related Cancer Trial in Baltimore (Havrix, PCV13)
Terminated
- Transplant-Related Cancer
- Havrix
- PCV13
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
May 8, 2019
Hepatitis A Trial in Beer-Sheva, Petach-Tikva (Epaxal, Havrix 720)
Completed
- Hepatitis A
- Epaxal
- Havrix 720
-
Beer-Sheva, Israel
- +1 more
Apr 4, 2019
Hepatitis A, Hepatitis B Trial in Gent (Blood sampling, Engerix-B, Havrix)
Completed
- Hepatitis A
- Hepatitis B
- Blood sampling
- +2 more
-
Gent, BelgiumGSK Investigational Site
Aug 31, 2018
Meningococcal Serogroup B Trial in Halifax (Bexsero®, Havrix®)
Completed
- Meningococcal Serogroup B
- Bexsero®
- Havrix®
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Jan 29, 2019
Influenza Trial in Alabang, Muntinlupa, Quezon City (Influenza vaccine GSK1562902A Formulation 1, Influenza vaccine GSK1562902A
Completed
- Influenza
- Influenza vaccine GSK1562902A Formulation 1
- +3 more
-
Alabang, Muntinlupa, Philippines
- +1 more
Aug 9, 2018
Infections, Streptococcal Trial in Santiago (Synflorix, Infanrix Hexa, Havrix)
Completed
- Infections, Streptococcal
- Synflorix
- +2 more
-
Santiago, Región Metro De Santiago, ChileGSK Investigational Site
Jun 8, 2018
Measles; Mumps; Rubella, Measles-Mumps-Rubella Vaccine Trial in Worldwide (Priorix, M-M-R II, Varivax)
Completed
- Measles; Mumps; Rubella
- Measles-Mumps-Rubella Vaccine
- Priorix
- +4 more
-
Birmingham, Alabama
- +94 more
Dec 15, 2020